Back to Search Start Over

Supplementary Table 1 from Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Authors :
Florence I. Raynaud
Udai Banerji
Paul Workman
Stanley B. Kaye
Johann S. de Bono
Suzanne A. Eccles
Valerie Meresse
Ruediger Rueger
Miro Venturi
Debra J. Skene
Victoria L. Revell
Alexis de haven Brandon
Gary Box
Melanie Valenti
Alan T. Henley
Yasmin J. Asad
Akos Pal
Joo Ern Ang
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Time of day variation in metabolites in healthy volunteers and in patients treated with the MEK inhibitor.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....83107465c9a5097e379e6d18c459f627
Full Text :
https://doi.org/10.1158/1535-7163.22508289.v1